Back to Search
KARL L INSOGNA MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1346223559Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
022077(CT)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
Hypophosphatemia promotes lower rates of muscle ATP synthesis.
PMID 27338702·FASEB J·2016
7-preclinical
The effect of proton pump-inhibiting drugs on mineral metabolism.
PMID 19262542·Am J Gastroenterol·2009
6-review
Can serum pentosidine levels predict risk of vertebral fracture in patients with type 2 diabetes mellitus?
PMID 18461065·Nat Clin Pract Endocrinol Metab·2008
8-other
Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women.
PMID 12412787·J Bone Miner Res·2002
7-preclinical
Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.
PMID 19661269·Blood·2009
8-other
Increasing dietary protein requirements in elderly people for optimal muscle and bone health.
PMID 19460090·J Am Geriatr Soc·2009
8-other
Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone.
PMID 19072724·J Bone Miner Res·2009
6-review
Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice.
PMID 19609735·Calcif Tissue Int·2009
7-preclinical
Targeted overexpression of the two colony-stimulating factor-1 isoforms in osteoblasts differentially affects bone loss in ovariectomized mice.
PMID 19141689·Am J Physiol Endocrinol Metab·2009
4-observational
Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial.
PMID 18978403·J Bone Joint Surg Am·2008
4-observational
A patient with hypophosphatemia, a femoral fracture, and recurrent kidney stones: report of a novel mutation in SLC34A3.
PMID 18996815·Endocr Pract·2008
5-case
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum.
PMID 19041748·Cell·2008
7-preclinical
The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice.
PMID 18467443·Endocrinology·2008
4-observational
An aerobic weight-loaded pilot exercise intervention for breast cancer survivors: bone remodeling and body composition outcomes.
PMID 18705153·Biol Res Nurs·2008
8-other
The role of the receptor activator of nuclear factor-kappaB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism.
PMID 18073309·J Clin Endocrinol Metab·2008
8-other
Proton pump-inhibiting drugs, calcium homeostasis, and bone health.
PMID 18254877·Nutr Rev·2008
6-review
Expression and synthesis of bone morphogenetic proteins by osteoclasts: a possible path to anabolic bone remodeling.
PMID 18319273·J Histochem Cytochem·2008
7-preclinical
Impact of glucose-dependent insulinotropic peptide on age-induced bone loss.
PMID 18072880·J Bone Miner Res·2008
7-preclinical
Effects of glucose-dependent insulinotropic peptide on osteoclast function.
PMID 17003233·Am J Physiol Endocrinol Metab·2007
7-preclinical
Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass.
PMID 17321229·Bone·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 789 HOWARD AVE, DANA BUILDING - 3RD FLOOR
NEW HAVEN, CT 06519 - Phone
- (203) 737-1932
Quick Facts
- NPI
- 1346223559
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile